Jones Financial Companies’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Jones Financial Companies’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$5.38M	Buy	34,618 +3,963	+13%	+$536K	﹤0.01%	1158
2026 Q1	$3.67M	Buy	30,655 +12,837	+72%	+$1.6M	﹤0.01%	1195
2025 Q4	$2.17M	Buy	17,818 +1,506	+9%	+$173K	﹤0.01%	909
2025 Q3	$1.6M	Sell	16,312 -229	-1%	-$20.6K	﹤0.01%	937
2025 Q2	$1.37M	Sell	16,541 -2,353	-12%	-$188K	﹤0.01%	883
2025 Q1	$1.59M	Sell	18,894 -1,773	-9%	-$158K	﹤0.01%	715
2024 Q4	$1.86M	Buy	20,667 +12,892	+166%	+$1.25M	﹤0.01%	580
2024 Q3	$765K	Buy	7,775 +6,734	+647%	+$662K	﹤0.01%	681
2024 Q2	$96.5K	Buy	1,041 +925	+797%	+$82.9K	﹤0.01%	1062
2024 Q1	$11K	Buy	+116	New	+$10.8K	﹤0.01%	1047
2023 Q1	–	Sell	-9	Closed	-$1K	–	793
2022 Q4	$1K	Buy	+9	New	+$729	﹤0.01%	720
2021 Q2	–	Sell	-34	Closed	-$5K	–	797
2021 Q1	$5K	Buy	+34	New	+$5.09K	﹤0.01%	633
2013 Q4	–	Sell	-267	Closed	-$11K	–	549
2013 Q3	$11K	Hold	267	–	–	﹤0.01%	509
2013 Q2	$9K	Buy	+267	New	+$9.38K	﹤0.01%	611

Other funds holding XBI

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

JFG

Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return

Jones Financial Companies's XBI Position: Q2 2026 in Review

Jones Financial Companies increased its State Street SPDR S&P Biotech ETF (XBI) stake by 13% in Q2 2026, buying an estimated $536K and bringing the position to 34,618 shares worth $5.38M. The position accounts for ﹤0.01% of the portfolio, ranked #1158.

Jones Financial Companies first reported a position in XBI in Q2 2013 and has held it in 14 quarters since. 932 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

Jones Financial Companies held 34,618 shares of State Street SPDR S&P Biotech ETF worth $5.38M as of Q2 2026.
Jones Financial Companies bought 3,963 State Street SPDR S&P Biotech ETF shares in Q2 2026, an estimated $536K.
State Street SPDR S&P Biotech ETF made up ﹤0.01% of Jones Financial Companies's portfolio in Q2 2026, its #1158 holding.
Jones Financial Companies first reported a position in State Street SPDR S&P Biotech ETF in Q2 2013 and has held it in 14 quarters since.
932 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on Jones Financial Companies's 13F filing for Q2 2026, filed 14 Aug 2026.